Vaxcyte (PCVX) Ending Cash Balance (2019 - 2026)
Vaxcyte (PCVX) reported Ending Cash Balance of $126.72 million for Q3 2026, down 55.2% from $282.55 million a year earlier and down 31.4% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Ending Cash Balance (2019 - 2026) Analysis & Trends
For FY2025, Vaxcyte posted Ending Cash Balance of $175.43 million, down 54.9% from FY2024.
- Ending Cash Balance has declined for three consecutive years, with a five-year compound annual growth rate of -14.6% (FY2020 to FY2025).
- By year, Ending Cash Balance came in at $389.2 million in FY2024 (-2.3%), $398.55 million in FY2023 (-52.3%), $835.53 million in FY2022 and $69.86 million in FY2021 (-81.9%).
- The Q3 2026 figure ranks as the lowest quarterly Ending Cash Balance since Q4 2021.
- Year over year, Ending Cash Balance has now declined in each of the last eight quarters, with an average decline of 41.8% over the last eight quarters.
- The high point for year-over-year Ending Cash Balance in five years was Q3 2022 (growth of 147.3%); the low point was Q4 2021 (a decline of 81.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $184.66 million (Q2 2026), $262.31 million (Q1 2026) and $175.43 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | 126.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 126.72 Mn |
| Jun 30, 2026 | 184.66 Mn |
| Mar 31, 2026 | 262.31 Mn |
| Dec 31, 2025 | 175.43 Mn |
| Sep 30, 2025 | 282.55 Mn |
| Jun 30, 2025 | 308.06 Mn |
| Mar 31, 2025 | 348.17 Mn |
| Dec 31, 2024 | 389.20 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 519.77 Mn |
| Mar 31, 2024 | 612.62 Mn |
| Dec 31, 2023 | 398.55 Mn |
| Sep 30, 2023 | 546.24 Mn |
| Jun 30, 2023 | 531.90 Mn |
| Mar 31, 2023 | 381.32 Mn |
| Dec 31, 2022 | 835.53 Mn |
| Sep 30, 2022 | 279.27 Mn |
| Jun 30, 2022 | 239.04 Mn |
| Mar 31, 2022 | 202.61 Mn |
| Dec 31, 2021 | 69.86 Mn |
API Access
Vaxcyte Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();